Insmed INSM
NASDAQ INSM
$126.38 -0.30 (-0.24%)
As of: Sep 4, 2026 · 12:48 PM EDT

Insmed (INSM) FCF Margin (2011 - 2026)

Insmed (INSM) posted quarterly FCF Margin of 73.94% for Q1 2026, up 21926.0% year-over-year from N/an in Q1 2025, and up 24.79% quarter-over-quarter from 98.31% in Q4 2025.

Analysis

Insmed (INSM) FCF Margin (2011 - 2026) Analysis & Trends

Insmed's FCF Margin history runs 11 years deep, the most recent figure standing at 73.94% for Q1 2026.

  • In Q1 2026, FCF Margin rose 21926.0% year-over-year to 73.94%; the TTM figure through Mar 2026 stood at 108.74% (up 9177.0% YoY), while the FY2025 annual figure was 154.54%, up 3120.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 73.94%, up from 98.31% in the prior quarter.
  • The five-year high for FCF Margin was 73.94% in Q1 2026, with the low at 293.2% in Q1 2025.
  • The 5-year median for FCF Margin is 168.64% (2022), against an average of 173.88%.
  • The sharpest annual moves came in 2025 and 2026: FCF Margin tumbled 7553 bps in 2025, then surged 21926 bps in 2026.
  • Insmed's FCF Margin stood at 168.64% in 2022, then increased by 6 bps to 158.88% in 2023, then dropped by 16 bps to 185.05% in 2024, then soared by 47 bps to 98.31% in 2025, then increased by 25 bps to 73.94% in 2026.
  • Business Quant data shows INSM's FCF Margin at 73.94% in Q1 2026, 98.31% in Q4 2025, and 138.08% in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn 30.39%
2 Regeneron Pharmaceuticals 85.72 Bn 77.72 Bn 3.93 Bn 13.35%
3 Argenx Se 63.56 Bn 58.38 Bn 1.37 Bn -
4 Moderna 57.87 Bn 52.73 Bn 52.00 Mn -388.28%
5 Revolution Medicines 44.06 Bn 44.06 Bn - -
6 BeOne Medicines 40.08 Bn 34.98 Bn 1.53 Bn 25.68%
7 Alnylam Pharmaceuticals 35.50 Bn 32.20 Bn 992.69 Mn 22.62%
8 Royalty Pharma 28.54 Bn 27.70 Bn - 70.82%
9 Insmed 27.49 Bn 26.33 Bn 358.27 Mn -22.35%
10 Incyte 25.59 Bn 21.06 Bn 1.57 Bn 29.58%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -22.35%
Mar 31, 2026 -73.94%
Dec 31, 2025 -100.13%
Sep 30, 2025 -156.09%
Jun 30, 2025 -213.46%
Mar 31, 2025 -271.40%
Dec 31, 2024 -194.13%
Sep 30, 2024 -226.67%
Jun 30, 2024 -113.54%
Mar 31, 2024 -249.95%
Dec 31, 2023 -160.09%
Sep 30, 2023 -183.32%
Jun 30, 2023 -162.95%
Mar 31, 2023 -232.36%
Dec 31, 2022 -194.55%
Sep 30, 2022 -128.92%
Jun 30, 2022 -171.02%
Mar 31, 2022 -209.86%
Dec 31, 2021 -156.03%
Sep 30, 2021 -157.87%